Veeva Systems secures UCB as a client for its Vault CRM platform, marking a strategic expansion of its agentic AI engagement tools within the life sciences sector.
Veeva Systems announced on Nov. 4, 2026 that UCB has committed to its Veeva Vault CRM agentic engagement platform for life sciences. The win adds a notable pharmaceutical customer for Veeva's flagship CRM product, supporting its subscription-based revenue outlook, though no financial terms or contract value were disclosed, limiting the magnitude of the move.
The announcement did not include any contract value or financial terms, so the revenue impact cannot be quantified from the disclosed information.
It is Veeva's agentic engagement platform for life sciences, providing industry-specific AI to support unified customer engagement worldwide.
Veeva Systems announced on November 4, 2026, that pharmaceutical company UCB has adopted its Vault CRM platform. The deal integrates Veeva's industry-specific AI to streamline unified customer engagement across UCB's global operations.
The selection marks a notable customer win for Veeva's flagship CRM product, reinforcing its position as a provider of agentic, industry-specific AI solutions for the life sciences industry.
The announcement did not disclose specific contract values or financial terms, making it impossible to quantify the immediate revenue impact on Veeva Systems.